BackgroundCheck.run
Search For

Nam Sook Kim, 741423 Gardiner Dr, Bayshore, NY 11706

Nam Kim Phones & Addresses

1423 Gardiner Dr, Bay Shore, NY 11706   

San Francisco, CA   

Woodmere, NY   

745 31St St, Brooklyn, NY 11210    718-8595197   

Mentions for Nam Sook Kim

Career records & work history

Lawyers & Attorneys

Nam Kim Photo 1

Nam Woo Kim - Lawyer

Address:
237-773988x (Office)
Licenses:
North Carolina - Authorized to practice law 2011
Nam Kim Photo 2

Nam Hee Kim - Lawyer

Address:
Pspd
Licenses:
New York - Currently registered 2012
Education:
Temple University - James E. Beasley School of Law
Nam Kim Photo 3

Nam E Kim - Lawyer

Licenses:
Dist. of Columbia - Active 2000
Nam Kim Photo 4

Nam Kim - Lawyer

Specialties:
Product Liability Defense, Insurance Coverage Litigation, Commercial Litigation, Contracts, Alternative Dispute Resolution, Automotive & Automotive Components, Consumer Products, Insurance & Reinsurance, Manufacturing, Distribution & Retail, Sports, Fitness & Recreation
ISLN:
1000983278
Admitted:
2020
University:
University of British Columbia, B.A.
Law School:
Hofstra University, J.D.

Medicine Doctors

Nam H. Kim

Specialties:
Cardiovascular Disease
Work:
Nam H Kim MD
501 Golder Ave STE 203A, Odessa, TX 79761
432-3319900 (phone)
Education:
Medical School
University of Texas Medical School at San Antonio
Graduated: 1988
Procedures:
Echocardiogram, Pacemaker and Defibrillator Procedures, Angioplasty, Cardiac Catheterization, Cardiac Rehabilitation, Cardiac Stress Test, Cardioversion, Continuous EKG, Electrocardiogram (EKG or ECG)
Conditions:
Acute Myocardial Infarction (AMI), Acute Pharyngitis, Acute Sinusitis, Acute Upper Respiratory Tract Infections, Angina Pectoris, Aortic Valvular Disease, Atrial Fibrillation and Atrial Flutter, Cardiac Arrhythmia, Cardiomyopathy, Diabetes Mellitus (DM), Disorders of Lipoid Metabolism, Heart Failure, Hypertension (HTN), Ischemic Heart Disease, Mitral Valvular Disease, Valvular Heart Disease
Languages:
English, Spanish
Description:
Dr. Kim graduated from the University of Texas Medical School at San Antonio in 1988. He works in Odessa, TX and specializes in Cardiovascular Disease.
Nam Kim Photo 5

Nam H Kim, Bronx NY

Specialties:
Speech-Language Pathology
Address:
5714 Post Rd, Bronx, NY 10471
Languages:
English

Nam E. Kim

Specialties:
Radiation Oncology
Work:
Lake Shore Cancer Care
5020 N Ashland Ave, Chicago, IL 60640
773-5060900 (phone) 773-5060909 (fax)
Education:
Medical School
Catholic Med Coll, Chongno Ku, Seoul, So Korea
Graduated: 1969
Conditions:
Malignant Neoplasm of Female Breast
Languages:
English, Korean, Polish, Spanish, Tagalog
Description:
Dr. Kim graduated from the Catholic Med Coll, Chongno Ku, Seoul, So Korea in 1969. He works in Chicago, IL and specializes in Radiation Oncology. Dr. Kim is affiliated with Methodist Hospital Of Chicago and Presence Saints Mary & Elizabeth Medical Center.
Nam Kim Photo 6

Nam Uk Kim

Specialties:
Internal Medicine
Hospitalist
Education:
Loma Linda University (2001)
Nam Kim Photo 7

Nam H Kim

Resumes & CV records

Resumes

Nam Kim Photo 55

Associate At Fenwick & West

Position:
Corporate Associate at Fenwick & West
Location:
Mountain View, California
Industry:
Law Practice
Work:
Fenwick & West since Sep 2012
Corporate Associate
Fenwick & West Jun 2011 - Aug 2011
Summer Associate
Kim & Chang Jun 2010 - Aug 2010
Summer Associate
Innovation Partners Jun 2006 - Sep 2009
IP Paralegal
Education:
University of Chicago Law School 2009 - 2012
J.D.
University of California, Berkeley 2002 - 2006
B.A.
Nam Kim Photo 56

Retired Baltimore City Police

Location:
Ellicott City, Maryland
Industry:
Security and Investigations
Work:
DirectBuy of Columbia Jun 2011 - Sep 2012
Director
Baltimore Police Department - Baltimore, Maryland Aug 1985 - Nov 2008
Detective
Interests:
Fishing and Golf
Honor & Awards:
Governor's Citation, 6 Mayor's Citations, South Korean National Police Appreciation Citation from the General, The Rotary Club of Woodlawn-Westview Service Award, Office of Inspector General Citation, Maryland Law Enforcement Officers, Inc. Certificate of Merit, The State's Attorney's Office Certificate of Achievement and many other awards from the Korean-American Communities.
Languages:
Korean
Nam Kim Photo 57

Nam Kim

Location:
San Francisco Bay Area
Industry:
Biotechnology
Languages:
Korea
Nam Kim Photo 58

Business Analysis And Reporting

Position:
Reporting Analyst at Apple
Location:
San Francisco Bay Area
Industry:
Telecommunications
Work:
Apple since Jan 2013
Reporting Analyst
Education:
University of California, Berkeley 1998 - 2002
B.A., Economics
Languages:
English
Korean
Certifications:
Certified Public Accountant, American Institute of Certified Public Accountants
SQL Certified Expert, Oracle
Project Management Professional, Project Management Institute
Nam Kim Photo 59

Nam Kim

Location:
Seattle, Washington
Industry:
Computer Software
Work:
Epic Jan 2009 - Jun 2012
Software Developer
Education:
University of Illinois at Urbana-Champaign 2004 - 2008
Bachelor of Science (B.S.), Computer Science
Nam Kim Photo 60

Nam Kim

Location:
United States
Nam Kim Photo 61

Nam Kim

Location:
United States
Nam Kim Photo 62

Nam Kim

Location:
United States

Publications & IP owners

Us Patents

Diagnostic Methods For Conditions Associated With Elevated Cellular Levels Of Telomerase Activity

US Patent:
6551774, Apr 22, 2003
Filed:
Aug 20, 1999
Appl. No.:
09/378535
Inventors:
Michael D. West - San Carlos CA
Calvin B. Harley - Palo Alto CA
Scott L. Weinrich - San Francisco CA
Catherine M. Strahl - San Francisco CA
Michael J. McEachern - San Francisco CA
Jerry Shay - Dallas TX
Woodring E. Wright - Arlington TX
Elizabeth H. Blackburn - San Francisco CA
Nam Woo Kim - Sunnyvale CA
Homayoun Vaziri - Toronto, CA
Assignee:
Board of Regents, The University of Texas System - Dallas TX
The Regents of the University of California - Oakland CA
Geron Corporation - Menlo Park CA
International Classification:
C12Q 168
US Classification:
435 6, 435 71, 435 15, 435 912, 435 915
Abstract:
Method and compositions are provided for the determination of telomere length and telomerase activity, as well as the ability to increase or decrease telomerase activity in the treatment of proliferative diseases. Particularly, primers are elongated under conditions which minimize interference from other genomic sequences, so as to obtain accurate determinations of telomeric length or telomerase activity. In addition, compositions are provided for intracellular inhibition of telomerase activity and means are shown for slowing or reversing the loss of telomeric repeats in aging cells.

Pro108 Antibody Compositions And Methods Of Use And Use Of Pro108 To Assess Cancer Risk

US Patent:
7294704, Nov 13, 2007
Filed:
Aug 16, 2004
Appl. No.:
10/919215
Inventors:
Iris Simon - San Franscisco CA, US
Laura Corral - San Francisco CA, US
Charis Lawrenson - San Jose CA, US
Nam Kim - Santa Clara CA, US
Glenn Pilkington - Sorrento, AU
Robert L. Wolfert - Palo Alto CA, US
Assignee:
diaDexus, Inc. - South San Francisco CA
International Classification:
C07K 16/00
US Classification:
5303881, 5303871, 5303873, 53038815, 4241411
Abstract:
This invention relates to a method for assessing risk of prostate cancer. Specifically, it relates to utilizing both Pro108 and Prostate Specific Antigen (PSA) in combination to determine the risk of prostate cancer. In addition, it is directed to a method for assessing risk of ovarian, colon, breast or stomach cancer utilizing Pro108 or specific antibodies to Pro108. The invention provides isolated anti-prostate, ovarian, colon, breast or stomach cancer antigen (Pro108) antibodies that bind to Pro108 on a mammalian cell in vivo. The invention also encompasses compositions comprising an anti-Pro108 antibody and a carrier. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-Pro108 antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-Pro108 antibodies.

Cable With Circuitry For Asserting Stored Cable Data Or Other Information To An External Device Or User

US Patent:
7500032, Mar 3, 2009
Filed:
Aug 31, 2007
Appl. No.:
11/848758
Inventors:
Ook Kim - Palo Alto CA, US
Eric Lee - San Jose CA, US
Gyudong Kim - Sunnyvale CA, US
Baegin Sung - Sunnyvale CA, US
Nam Hoon Kim - Cupertino CA, US
Gijung Ahn - San Jose CA, US
Seung Ho Hwang - Palo Alto CA, US
Assignee:
Silicon Image, Inc - Sunnyvale CA
International Classification:
G06F 13/38
US Classification:
710 72
Abstract:
A cable including circuitry for asserting information to a user or external device and a system including such a cable. The cable can include conductors, a memory storing cable data, and circuitry configured to respond to a request received on at least one of the conductors by accessing at least some of the cable data and asserting the accessed data serially to at least one of the conductors (e. g. , for transmission to an external device). Other aspects of the invention are methods for accessing cable data stored in a cable and optionally using the data (e. g. , to implement equalization). The cable data can be indicative of all or some of cable type, grade, speed, length, and impedance, a date code, a frequency-dependent attenuation table, far-end crosstalk and EMI-related coefficients, common mode radiation, intra pair skew, and other information. The cable can include a radiation-emitting element and circuitry for generating driving signals for causing the radiation-emitting element to produce an appropriate color, brightness, and/or blinking pattern.

Cln101 Antibody Compositions And Methods Of Use Alone And In Combination With Prostate Specific Antigen And Other Cancer Markers

US Patent:
7560531, Jul 14, 2009
Filed:
Jun 1, 2004
Appl. No.:
10/558543
Inventors:
Xiaozhu Duan - Alameda CA, US
Nam Kim - Santa Clara CA, US
Robert L. Wolfert - Palo Alto CA, US
Assignee:
diaDexus, Inc. - South San Francisco CA
International Classification:
A61K 38/48
US Classification:
5303871
Abstract:
This invention relates to a method for assessing risk of prostate and/or ovarian cancer. Specifically, in one embodiment it relates to utilizing both Cln101 and Prostate Specific Antigen (PSA) in combination to determine the risk of prostate cancer. In an alternative embodiment, the invention is relates to utilizing Cln101 alone or in combination with CA125 to determine the risk of ovarian cancer. The invention further provides isolated anti-prostate or ovarian cancer antigen (Cln101) antibodies that bind to Cln101 in vivo. The invention also encompasses compositions comprising an anti-Cln101 antibody and a carrier. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-Cln101 antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-Cln101 antibodies. The invention encompasses a method of producing the anti-Cln10I antibodies.

Pro108 Antibody Compositions And Methods Of Use And Use Of Pro108 To Assess Cancer Risk

US Patent:
8148093, Apr 3, 2012
Filed:
Oct 3, 2007
Appl. No.:
11/866475
Inventors:
Iris Simon - San Francisco CA, US
Laura Corral - San Francisco CA, US
Charis Lawrenson - San Jose CA, US
Nam Kim - Santa Clara CA, US
Glenn Pilkington - Sorrento, AU
Robert L. Wolfert - Palo Alto CA, US
Assignee:
diaDexus, Inc. - South San Francisco
International Classification:
G01N 33/53
G01N 33/574
G01N 33/60
US Classification:
435 723, 435 71, 435 72, 435 721, 435 76, 436501, 436503, 436504, 436 63, 436 64
Abstract:
This invention relates to a method for assessing risk of prostate cancer. Specifically, it relates to utilizing both Pro108 and Prostate Specific Antigen (PSA) in combination to determine the risk of prostate cancer. In addition, it is directed to a method for assessing risk of ovarian, colon, breast or stomach cancer utilizing Pro108 or specific antibodies to Pro108. The invention provides isolated anti-prostate, ovarian, colon, breast or stomach cancer antigen (Pro108) antibodies that bind to Pro108 on a mammalian cell in vivo. The invention also encompasses compositions comprising an anti-Pro108 antibody and a carrier. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-Pro108 antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-Pro108 antibodies.

Cable With Circuitry For Asserting Stored Cable Data Or Other Information To An External Device Or User

US Patent:
7269673, Sep 11, 2007
Filed:
Feb 18, 2004
Appl. No.:
10/781405
Inventors:
Ook Kim - Palo Alto CA, US
Eric Lee - San Jose CA, US
Gyudong Kim - Sunnyvale CA, US
Baegin Sung - Sunnyvale CA, US
Nam Hoon Kim - Cupertino CA, US
Gijung Ahn - San Jose CA, US
Seung Ho Hwang - Palo Alto CA, US
Assignee:
Silicon Image, Inc. - Sunnyvale CA
International Classification:
G06F 13/38
US Classification:
710 72
Abstract:
A cable including circuitry for asserting information to a user or external device and a system including such a cable. The cable can include conductors, a memory storing cable data, and circuitry configured to respond to a request received on at least one of the conductors by accessing at least some of the cable data and asserting the accessed data serially to at least one of the conductors (e. g. , for transmission to an external device). Other aspects of the invention are methods for accessing cable data stored in a cable and optionally using the data (e. g. , to implement equalization). The cable data can be indicative of all or some of cable type, grade, speed, length, and impedance, a date code, a frequency-dependent attenuation table, far-end crosstalk and EMI-related coefficients, common mode radiation, intra pair skew, and other information. The cable can include a radiation-emitting element and circuitry for generating driving signals for causing the radiation-emitting element to produce an appropriate color, brightness, and/or blinking pattern.

Methods Of Screening For Compounds That Derepress Or Increase Telomerase Activity

US Patent:
2003019, Oct 9, 2003
Filed:
Aug 29, 2002
Appl. No.:
10/232927
Inventors:
Michael West - San Carlos CA, US
Calvin Harley - Palo Alto CA, US
Scott Weinrich - San Francisco CA, US
Catherine Strahl - San Francisco CA, US
Michael McEachern - San Francisco CA, US
Jerry Shay - Dallas TX, US
Woodring Wright - Arlington TX, US
Elizabeth Blackburn - San Francisco CA, US
Nam Kim - Sunnyvale CA, US
Homayoun Vaziri - Toronto, CA
Assignee:
Board of Regents, The University of Texas System
International Classification:
C12Q001/68
A61K031/00
A61K045/00
A61K009/127
C12N005/08
US Classification:
435/006000, 424/450000, 424/093700, 514/001000, 435/372000
Abstract:
Method and compositions are provided for the determination of telomere length and telomerase activity, as well as the ability to increase or decrease telomerase activity in the treatment of proliferative diseases. Particularly, primers are elongated under conditions which minimize interference from other genomic sequences, so as to obtain accurate determinations of telomeric length or telomerase activity. In addition, compositions are provided for intracellular inhibition of telomerase activity and means are shown for slowing or reversing the loss of telomeric repeats in aging cells.

Methods Of Detecting Lp-Pla2 Activity

US Patent:
2007028, Dec 6, 2007
Filed:
Feb 3, 2005
Appl. No.:
10/588339
Inventors:
Robert Wolfert - Palo Alto CA, US
Nam Kim - Santa Clara CA, US
Xiazhu Duan - Alameda CA, US
International Classification:
G01N 33/573
C12Q 1/34
US Classification:
435007400, 435018000
Abstract:
This invention relates to a method for measuring enzymatically active Lipoprotein Phospholipase A2 (Lp-PLA2) in a sample. Further, this invention relates to a Hybrid Immunocapture method for measuring enzymatically active Lp-PLA2 in a sample. Specifically, this invention relates to a Hybrid Immunocapture method for measuring enzymatically active Lp-PLA2 in a sample utilizing an enzymatically active Lp-PLA2 standard. In addition, this invention relates to a kit for measuring enzymatically active Lp-PLA2 in a sample. Specifically, this invention relates to a kit for measuring enzymatically active Lp-PLA2 in a sample containing an enzymatically active Lp-PLA2 standard.

Isbn (Books And Publications)

Structural Sensitivity Analysis And Optimization 2: Nonlinear Systems And Applications

Author:
Nam H. Kim
ISBN #:
0387233369

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.